Form 4: Molina Healthcare CFO Mark Keim Reports Stock Transactions
SEC Form 4 Filing
Molina Healthcare's CFO, Mark Keim, reports acquisition and disposal of company stock, including shares from performance stock units and restricted stock grants.
Summary
- Mark Keim, CFO of Molina Healthcare, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On March 1, 2025, Keim acquired 10,748 shares of common stock at $301.12 per share as settlement of performance stock units.
- He also disposed of 5,053 shares and 2,480 shares on the same day to cover withholding taxes related to the vesting of performance stock units.
- Additionally, Keim acquired 8,677 shares of restricted stock at a VWAP of $288.12 under the company's 2019 Equity Incentive Plan.
- Following these transactions, Keim beneficially owns 59,486 shares of Molina Healthcare common stock.
- A prior power of attorney document was included, signed in 2018, granting Jeff D. Barlow and Codruta Boggs the authority to file Section 16(a) forms on Keim's behalf.
Sentiment
Score: 6
Explanation: Neutral sentiment as the document primarily reports routine stock transactions by a company executive. The vesting of performance stock units is a slightly positive indicator, while the sale of shares for tax purposes is a neutral event.
Positives
- The vesting of performance stock units indicates potential achievement of company performance goals.
- The grant of restricted stock aligns executive interests with long-term company performance.
Negatives
- Disposal of shares to cover withholding taxes reduces Keim's overall stake in the company.
Future Outlook
The restricted stock grant vests in increments on March 1, 2026, March 1, 2027, and March 1, 2028.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor executive compensation and potential alignment with company performance.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, restricted stock, and performance-based incentives.
- The vesting schedules for restricted stock are typical, designed to retain executives and align their interests with long-term shareholder value.
- Companies like UnitedHealth Group (UNH) and Cigna (CI) also utilize similar equity-based compensation strategies for their executives.
Stakeholder Impact
- Shareholders can monitor insider transactions for insights into management's view of the company's prospects.
- Employees may be impacted by the company's performance, which affects the vesting of performance-based equity awards.
Key Dates
| Date | Description |
|---|---|
| 2018/03/09 | Date of Limited Power of Attorney for Section 16(a) Filings |
| 2022/03/01 | Date of performance stock units grant that vested on March 1, 2025 |
| 2025/02/28 | Closing price of Issuer's common stock used for share calculations |
| 2025/03/01 | Date of stock transactions: acquisition of shares from performance stock units, disposal for tax withholding, and grant of restricted stock |
| 2025/03/01 | Date of vesting of 5,273 shares |
| 2025/03/04 | Date of Form 4 filing |
| 2026/03/01 | First vesting date for one-third of the 8,677 newly granted restricted shares and 3,670 additional shares |
| 2027/03/01 | Second vesting date for one-third of the 8,677 newly granted restricted shares and 1,721 additional shares |
| 2028/03/01 | Final vesting date for one-third of the 8,677 newly granted restricted shares |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.